Blog

Symbyax (fluoxetine and olanzapine) is a prescription antidepressant that is intended to assist in the treatment of several major depressive disorders and generalized anxiety. However, a unique combination formula allows Symbyax to treat a number of related psychotic disorders as well. Unfortunately, the introduction of Symbyax to a developing fetus may result in catastrophic…

Craniosynostosis is a cranial skull defect characterized by the premature closing of one or more joints in your infant’s skull. As a result, their brain can not grow to its natural shape and the head becomes misshapen. In this article we will discuss the signs and symptoms, causes, complications, tests and diagnosis for craniosynostosis….

Once touted as a revolutionary breakthrough in the treatment of obesity, Fen Phen was a dual action dietary supplement, capable of promoting weight loss. However, clinical trials began to suggest that one component of the dual action formula may have been responsible for catastrophic side effects. Those who implemented a strict Fen Phen regimen…

Aclasta (generic: zoledronic acid) is a medication that inhibits the release of calcium from a patients skeletal structure. Unfortunately, individuals prescribed this medication may be unaware of the dangerous Aclasta side effects that coincide with it. The use of Aclasta may increase the risk of debilitating complications including low energy femur fractures and osteonecrosis…

2006 marked, what was to be considered, the genesis of Zimmer’s next generation total joint replacement systems. The company introduced the Zimmer Durom Cup hip replacement system to the U.S. market as a revolutionary piece of equipment intended as the next step in orthopedic solutions. However, the device became synonymous with faulty components that…

Transgressions committed by dietary supplement manufacturers continue to cast doubt throughout the entire industry. Increasingly, companies are neglecting to follow the laws set forth by federal authorities. Of significant concern, however, is the current trend of adding undisclosed and potentially dangerous active ingredients to dietary supplements. The U.S. Food and Drug Administration (FDA) has…

DMAA, otherwise known as Dimethylamylamine, is a controversial ingredient in several dietary supplements that tout the miraculous ability to increase workout energy and efficiency. Of significant concern, however, is the exponential increase of adverse health reports that have been associated with the ingestion of DMAA-containing dietary supplements. Complicating the volatile situation, is a shroud…

The decision on March 4, 2011, by FDA to require the manufacturers of the anti-seizure drug topiramate (Topamax) to significant strengthen warnings for woman who are or may become pregnant comes almost three years after a British epidemiological study raised serious questions concerning safety of the drug during pregnancy. FDA is now requiring the…